Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude+Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
AbbVie
(NY:
ABBV
)
210.77
+2.27 (+1.09%)
Official Closing Price
Updated: 7:00 PM EDT, May 14, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
5,005,462
Open
209.50
Bid (Size)
211.60 (100)
Ask (Size)
211.95 (500)
Prev. Close
208.50
Today's Range
208.35 - 213.51
52wk Range
176.57 - 244.81
Shares Outstanding
N/A
Dividend Yield
3.28%
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
5 Stocks to Own For the Next 10 Years
↗
Today 13:41 EDT
All High Quality Names
Via
The Motley Fool
CNS Drug Delivery Technologies Are Reshaping Alzheimer’s and Biodefense Research
May 13, 2026
Via
Investor Brand Network
Performance
YTD
-8.1%
-8.1%
1 Month
+2.1%
+2.1%
3 Month
-4.6%
-4.6%
6 Month
-9.6%
-9.6%
1 Year
+12.1%
+12.1%
More News
Read More
Next-Generation GLP-1 Innovation Could Unlock Massive Metabolic Healthcare Market Opportunities
May 13, 2026
Via
Investor Brand Network
InvestorNewsBreaks – SureNano Science Ltd. (CSE: SURE) (OTCQB: SURNF) Featured in BioMedWire Editorial on Next-Generation GLP-1 Innovation
May 13, 2026
Via
Investor Brand Network
InvestorNewsBreaks – Oncotelic Therapeutics, Inc. (OTCQB: OTLC) Featured in BioMedWire Editorial on Next-Generation CNS Drug Delivery
May 13, 2026
Via
Investor Brand Network
Topics
Intellectual Property
3 Reasons to Buy AbbVie Stock (ABBV) Like There's No Tomorrow
↗
May 12, 2026
Via
The Motley Fool
Topics
Intellectual Property
A Tiny Biotech Just Beat AbbVie's $17 Billion Drug. Should Investors Be Worried?
↗
May 11, 2026
Via
The Motley Fool
Next-Generation GLP-1 Innovation Could Unlock Massive Metabolic Healthcare Market Opportunities
May 13, 2026
From
BioMedWire
Via
GlobeNewswire
2 Cash-Producing Stocks to Research Further and 1 We Find Risky
May 11, 2026
Via
StockStory
CNS Drug Delivery Technologies Are Reshaping Alzheimer’s and Biodefense Research
May 13, 2026
From
BioMedWire
Via
GlobeNewswire
What This Fund’s $4 Million Apollo Commercial Real Estate Finance Sale Could Signal About CRE Risk
↗
May 10, 2026
Via
The Motley Fool
Topics
Regulatory Compliance
What to Know About This Fund’s $3 Million Blackstone Mortgage Trust Sale Amid Office Stress
↗
May 10, 2026
Via
The Motley Fool
AbbVie Touts Record Sales and Pipeline Momentum at Annual Meeting
↗
May 09, 2026
Via
MarketBeat
Safer Dividend King to Buy Now: AbbVie or Johnson & Johnson?
↗
May 06, 2026
Via
The Motley Fool
Topics
Intellectual Property
Want Reliable Dividend Income in May? These 2 Stocks Deliver
↗
May 06, 2026
Via
The Motley Fool
Topics
Economy
Intellectual Property
5 Must-Read Analyst Questions From AbbVie’s Q1 Earnings Call
May 06, 2026
Via
StockStory
Topics
Earnings
Want to Collect a High Dividend Every Month? Invest in These 3 Stocks
↗
May 05, 2026
Via
The Motley Fool
Topics
Intellectual Property
AbbVie's Latest Results Reveal a Trend Investors Shouldn't Overlook
↗
May 04, 2026
Via
The Motley Fool
3 of the Best Dividend Stocks to Buy in May 2026
↗
May 04, 2026
Via
The Motley Fool
Topics
Intellectual Property
The Best Stocks to Buy With $1,000 Right Now
↗
May 03, 2026
Via
The Motley Fool
Topics
Artificial Intelligence
Earnings
The Most Important Part of These 3 Big Pharma Earnings Reports Wasn’t the Beat
↗
May 02, 2026
Via
MarketBeat
MarketBeat Week in Review – 04/27 - 05/01
↗
May 02, 2026
Via
MarketBeat
Aqua Medical Spa Launches New Website to Showcase Aesthetic and Wellness Services in London, ON
May 01, 2026
Via
GetFeatured
ABBV Q1 Deep Dive: Immunology and Neuroscience Growth, Raised Full-Year Outlook
April 30, 2026
Via
StockStory
EDMP picks up Sonoco, and the position size is doing the talking
↗
April 29, 2026
Via
The Motley Fool
Topics
Regulatory Compliance
Frequently Asked Questions
Is AbbVie publicly traded?
Yes, AbbVie is publicly traded.
What exchange does AbbVie trade on?
AbbVie trades on the New York Stock Exchange
What is the ticker symbol for AbbVie?
The ticker symbol for AbbVie is ABBV on the New York Stock Exchange
What is the current price of AbbVie?
The current price of AbbVie is 210.77
When was AbbVie last traded?
The last trade of AbbVie was at 05/14/26 07:00 PM ET
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.